Preparation of Live Attenuated Corynebacterium pseudotuberculosis Vaccine against Caseous Lymphadenitis in Sheep | ||||
| Egyptian Journal of Veterinary Sciences | ||||
| Articles in Press, Corrected Proof, Available Online from 22 July 2025 PDF (1.22 MB) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejvs.2025.382503.2832 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Marwah M Mohamed   1; Elham F El-Sergany2; Roukaya M Osman2; Nadine A El Sebaie3
| ||||
| 1Bacterial Diagnostic Products Department, Veterinary Serum and Vaccine Research Institute (VSVRI), Agriculture Research Center (ARC), Cairo, Egypt. | ||||
| 2Anaerobic Bacterial Vaccine Research Department, Veterinary Serum and Vaccine Research Institute (VSVRI), Agriculture Research Center (ARC), Cairo, Egypt. | ||||
| 3Genetic Engineering Research Department, Veterinary serum and Vaccines research institute, Cairo, Egypt. | ||||
| Abstract | ||||
| Caseous lymphadenitis (CLA) is a chronic granulomatous disease commonly occur in small ruminants, caused by a gram positive Corynebacterium pseudotuberculosis. The present study aimed to identify the suitable attenuation method for Corynebacterium pseudotuberculosis Ovis and to evaluate the immunogenicity of the resulting live attenuated vaccine in sheep. Various attenuation methods were assessed, including; thermal treatment at 55 °C for 15 minutes, exposure to alkaline pH (pH11) and treatment with crystal violet (1/ 250.000 concentration). These methods resulted in significant alteration in the bacteria cultural and biochemical characteristics, as well as a reduction in its virulence by decreasing the invasive power of the ovine strain. The strain attenuated using crystal violet was selected for vaccine formulation. Ten native sheep were vaccinated with the crystal violet live attenuated C. ovis vaccine, humoral and cellular immune response were assessed. Results demonstrated that, the prepared live attenuated vaccine induce a robust immune response, indicating its potential efficacy. In conclusion, the developed live attenuated C. ovis vaccine is safe and eliciting a strong immune response in sheep which represents a promising strategy for controlling of the CLA infection in sheep with potential to reduce the economic impact of the disease in sheep industry. | ||||
| Keywords | ||||
| Attenuated vaccine; C. ovis; Gamma interferon; Lymphocyte proliferation; Sheep | ||||
|
Statistics Article View: 50 PDF Download: 32 |
||||
